Viewing Study NCT02171195


Ignite Creation Date: 2025-12-24 @ 2:12 PM
Ignite Modification Date: 2026-02-26 @ 4:17 PM
Study NCT ID: NCT02171195
Status: COMPLETED
Last Update Posted: 2016-07-20
First Post: 2014-06-20
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: A Single Centre, Phase I, Double-blind, Randomised, Placebo-controlled Study to Investigate the Safety, Tolerability, Pharmacokinetic Profile and Effects on EEG of Single Rising Oral Doses of BIA 2-093
Sponsor: Bial - Portela C S.A.
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: BIA-2093-101
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators